| Events
Column |
|
| 9/17.
8:00 am - 5:30 pm. Connecticut Stem Cell Technology
Symposium: Molecular Advances in the Discovery and
Translation of Stem Cell Research. Keynote Address: Ronald
Hart, Ph.D., Rutgers Stem Cell Research Center. Marriott,
Farmington. more |
|
| 9/19. Next
is Now: New Frontiers in DNA Sequencing. McMillan Center,
Yale University, New Haven. more |
|
|
|
Exiciting
and Challenging New Season Approaches
From
the desk of Paul Pescatello, President and CEO of CURE
 For CURE, as for many Connecticut organizations, Labor Day marks a watershed in the annual calendar of events. Behind us lies another
spectacular Connecticut summer, and ahead we can already see the cluster beginning to hum with new activity.
CURE member organizations have continued to make news, and
we are putting together exciting new programs for the coming
season.
For
the full story |
|
CURE
Cookout Draws Biotech Crowd to Branford
 Back by popular demand, the CURE summer biotech cookout was held again this year at the Owenego Inn in Branford.
More than 175 employees and friends of CURE member organizations
registered for the July 17 event, playing the DNA Game, sampling the hot and cold buffet, and networking in the sunshine along the beautiful
Connecticut shoreline.
For
the full story |
|
Optherion
Biggest CT Venture Capital Draw in Q2
The largest single venture
capital investment in Connecticut in the second quarter of
2008 went to Branford-based biotech Optherion, according to
the MoneyTree™ report from PricewaterhouseCoopers and the
National Venture Capital Association, based on data provided
by Thomson Reuters. Separately, for the fiscal year ending
June 30, Connecticut Innovations invested $11.5 million in
18 companies, up from $6.9 million in the 2007 fiscal year.
For
the full story |
|
CURE
Member News Digest
 454
Life Sciences reports
Neanderthal genome sequencing
Achillion
CEO cites Q2 progress
Alexion
announces new patent
Applied
Spine device implanted in local man
Bayer
HealthCare cites Nexavar® progress
Boehringer
Ingelheim reports Aptivus® approval
Bristol-Myers
Squibb offers ReSEARCH program to students
Cantor
Colburn newsletter reviews trademark case
Connecticut
Innovations named to top 100 list
CuraGen pleased
with Q2 progress
Danbury
Hospital heart center offers newest stents
GlaxoSmithKline
reports results on HuMax-CD20®
Hartford
Hospital welcomes electrophysiology head
HistoRx names
diagnostic operations head
Ipsogen wins
CE marking for JAK2 test
Johnson
& Johnson cites VisiCare Institute™ role
at Olympics
MannKind
to host plant dedication in Danbury
NanoViricides
sees efficacy for its EKC-Cide™ for eyes
Neurogen focuses
of Phase 2 drug
Pfizer
promotes Cerenia™ drug for dogs
PhRMA
dreports on mental illness drugs
Purdue
Pharma unveils tookkit for pain management
Quinnipiac
University to offer online OT courses
Rib-X
names George Milne executive chairman
Triumvirate
Environmental acquires Enviro-Safe branches
UConn
researchers report in nanotechnology publication
Vion
to test Cloretazine® with
Dutch group
Yale
identifies West Nile genes
For
the full story |
|
